References
- Abbosh, C., Birkbak, N. J., Swanton, C. (2018). Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection. Nat. Rev. Clin. Oncol., 15, 577–586.10.1038/s41571-018-0058-329968853
- Alama, A., Coco, S., Genova, C., Rossi, G., Fontana, V., Tagliamento, M., Dal Bello, M. G., Rosa, A., Boccardo, S., Rijavec, E., Biello, F., Longo, L., Cavalieri, Z., Bruzzo, C., Grossi, F. (2019). Prognostic relevance of circulating tumor cells and circulating cell-free DNA association in metastatic non-small cell lung cancer treated with nivolumab. J. Clin. Med., 8, 1011.10.3390/jcm8071011667911731295929
- Al-Ayoubi, A. M., Flores, R. M. (2016). Management of CT screen-detected lung nodule: The thoracic surgeon perspective. Ann. Transl. Med., 4, 156.10.21037/atm.2016.03.49486048727195274
- Amiri, A., Pourhanifeh, M. H., Mirzaei, H. R., Nahand, J. S., Moghoofei, M., Sahebnasagh, R., Mirzaei, H., Hamblin, M. R. (2021). Exosomes and lung cancer: Roles in pathophysiology, diagnosis and therapeutic applications. Curr. Med. Chem., 28, 308–328.10.2174/092986732766620020414195232013817
- Anzidei, M., Porfiri, A., Andrani, F., Di Martino, M., Saba, L., Catalano, C., Bezzi, M. (2017). Imaging-guided chest biopsies: techniques and clinical results. Insights Imaging, 8, 419–428.10.1007/s13244-017-0561-6551950028639114
- Babu, N., Advani, J., Solanki, H. S., Patel, K., Jain, A., Khan, A. A., Radhakrishnan, A., Sahasrabuddhe, N. A., Mathur, P. P., et al. (2018). miRNA and proteomic dysregulation in non-small cell lung cancer in response to cigarette smoke. Microrna., 7, 38–5310.2174/221153660766618010316534329299995
- Best, M. G., Sol, N., Kooi, I., Tannous, J., Westerman, B. A., Rustenburg, F., Schellen, P., Verschueren, H., Post, E., Koster, J., et al. (2015). RNA-Seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics. Cancer Cell., 28, 666–676.10.1016/j.ccell.2015.09.018464426326525104
- Bueno, J., Landeras, L., Chung, J. H. (2018). Updated Fleischner Society Guidelines for Managing Incidental Pulmonary Nodules: Common questions and challenging scenarios. Radiographics, 38, 1337–1350.10.1148/rg.201818001730207935
- Cainap, C., Pop, L. A., Balacescu, O., Cainap, S. S. (2020). Early diagnosis and screening in lung cancer. Amer. J. Cancer. Res., 10, 1993–2009.10.3390/biology10090864
- Carstensen, T., Schmidt, B., Engel, E., Jandrig, B., Witt, C., Fleischhacker, M. (2004). Detection of cell-free DNA in bronchial lavage fluid supernatants of patients with lung cancer. Ann. N. Y. Acad. Sci., 1022, 202–210.10.1196/annals.1318.03115251961
- Chen, M., Zhao, H. (2019). Next-generation sequencing in liquid biopsy: Cancer screening and early detection. Hum. Genomics, 13, 34.10.1186/s40246-019-0220-8
- Chung, C., Kim, Y., Park, D. (2020). Transthoracic needle biopsy: How to maximize diagnostic accuracy and minimize complications. Tuberc. Respir. Dis., 83, 17–24.10.4046/trd.2020.0156783737733272004
- de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020). Reduced lung-cancer mortality with volume CT screening in a randomized trial. New Engl. J. Med., 382, 503–513.10.1056/NEJMoa1911793
- Di Bardino, D. M., Yarmus, L. B., Semaan, R. W. (2015). Transthoracic needle biopsy of the lung. J. Thorac. Dis., 7, 304–316.
- Dionísio, J. (2012). Diagnostic flexible bronchoscopy and accessory techniques. Rev. Port. Pneumol., 18, 99–106.10.1016/j.rppneu.2012.01.003
- Dziedzic, R., Marjański, T., Rzyman, W. (2021). A narrative review of invasive diagnostics and treatment of early lung cancer. Transl. Lung Cancer Res., 10, 1110–1123.10.21037/tlcr-20-728
- Elicker, B. M. (2021). Lung nodule risk calculator and cost-effectiveness of different lung cancer screening algorithms. Radiol. Cardiothorac. Imaging, 3, e210050.10.1148/ryct.2021210050
- Eslami, S. Z., Cortés-Hernández, L. E., Alix-Panabières, C. (2020). Epithelial cell adhesion molecule: An anchor to isolate clinically relevant circulating tumor cells. Cells, 9, 1836.10.3390/cells9081836
- Francisci, S., Minicozzi, P., Pierannunzio, D., Ardanaz, E., Eberle, A., Grimsrud, T. K., Knijn, A., Pastorino, U., Salmerón, D., Trama, A., Sant, M. (2015). EUROCARE-5 Working Group. Survival patterns in lung and pleural cancer in Europe 1999–2007: Results from the EUROCARE-5 study. Eur. J. Cancer, 51, 2242–2253.10.1016/j.ejca.2015.07.033
- Freitas, C., Sousa, C., Machado, F., Serino, M., Santos, V., Cruz-Martins, N., Teixeira, A., Cunha, A., Pereira, T., Oliveira, H. P., Costa, J. L., Hespanhol, V. (2021). The role of liquid biopsy in early diagnosis of lung cancer. Front. Oncol., 11, 634316.10.3389/fonc.2021.634316
- Gregoire, G., Pralong, J. A., Combescure, C., Seijo, L. M., Rochat, T., Soccal., P. M. (2014). Diagnostic yield and safety of electromagnetic navigation bronchoscopy for lung nodules: A systematic review and meta-analysis. Respiration, 87, 165–176.10.1159/000355710
- Ginsberg, R. J., Rubinstein, L. V. (1995). Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann. Thorac. Surg., 60, 615–622.10.1016/0003-4975(95)00537-U
- Gould, M. K., Donington, J., Lynch, W. R., Mazzone, P. J., Midthun, D. E., Naidich, D. P., Wiener, R. S. (2013). Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 143, 93–120.10.1378/chest.12-2351374971423649456
- Guarize, J., Bianchi, F., Marino, E., Belloni, E., Vecchi, M., Donghi, S., Lo Iacono, G., Casadio, C., Cuttano, R., Barberis, M., Di Fiore, P.P., Petrella, F., Spaggiari, L. (2018). MicroRNA expression profile in primary lung cancer cells lines obtained by endobronchial ultrasound transbronchial needle aspiration. J. Thorac. Dis., 10, 408–415.10.21037/jtd.2017.12.69586314429600073
- Guibert, N., Pradines, A., Favre, G., Mazieres, J. (2020). Current and future applications of liquid biopsy in non-small cell lung cancer from early to advanced stages. Eur. Respir. Rev., 29, 190052.10.1183/16000617.0052-2019
- Guo, Q. R., Wang, H., Yan, Y. D., Liu, Y., Su, C. Y., Chen, H. B., Yan, Y. Y., Adhikari, R., Wu, Q., Zhang, J. Y. (2020). The role of exosomal microRNA in cancer drug resistance. Front. Oncol., 10, 472.10.3389/fonc.2020.00472715413832318350
- Hammer, M. M., Gupta, S., Kong, C. Y. (2021). Cost-effectiveness of management algorithms for lung-RADS category 4 nodules. Radiol. Cardiothorac. Imaging, 3, 200523.10.1148/ryct.2021200523809808833969309
- Haber, D. A., Velculescu, V. E. (2014). Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA. Cancer. Discov., 4, 650–661.10.1158/2159-8290.CD-13-1014443354424801577
- Heerink, W. J., de Bock, G. H., de Jonge, G. J., Groen, H. J., Vliegenthart, R., Oudkerk, M. (2017). Complication rates of CT-guided transthoracic lung biopsy: Meta-analysis. Eur. Radiol., 27, 138–148.10.1007/s00330-016-4357-8512787527108299
- Huang, L., Rong, Y., Tang, X., Yi, K., Wu, J., Wang, F. (2021). Circular RNAs are promising biomarkers in liquid biopsy for the diagnosis of non-small cell lung cancer. Front. Mol. Biosci. 8, 625722.10.3389/fmolb.2021.625722820160434136531
- Husain, H., Melnikova, V. O., Kosco, K., Woodward, B., More, S., Pingle, S. C., Weihe, E., Park, B. H., Tewari, M., Erlander, M. G., Cohen, E., Lippman, S. M., Kurzrock, R. (2017). Monitoring daily dynamics of early tumor response to targeted therapy by detecting circulating tumor DNA in urine. Clin. Cancer. Res., 23, 4716-4723.10.1158/1078-0432.CCR-17-0454573773528420725
- In ‘t Veld, S. G. J. G., Wurdinger, T. (2019). Tumor-educated platelets. Blood, 133, 2359–2364.10.1182/blood-2018-12-85283030833413
- Iqbal, M. A., Arora, S., Prakasam, G., Calin, G. A., Syed, M. A. (2019). MicroRNA in lung cancer: Role, mechanisms, pathways and therapeutic relevance. Mol. Aspects Med., 70, 3–20.10.1016/j.mam.2018.07.00330102929
- Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., Knippers, R. (2001). DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res., 61, 1659–1665.
- Krams, A., Stengrevics, A., Snipe, R., Cernavska, I., Krejere, I., Silins, I. (2007). Histological types of lung cancer in Latvia. Proc. Latvian Acad. Sci. Section B, 61, 193–200.
- Kwapisz, D. (2017). The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer? Ann. Transl. Med., 5, 46.10.21037/atm.2017.01.32
- Lee, J. Y., Qing, X., Xiumin, W., Yali, B., Chi, S., Bak, S. H., Lee, H. Y., Sun, J.-M., Lee, S.-H., Ahn, J. S. et al. (2016). Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02). Oncotarget, 7, 6984–6993.10.18632/oncotarget.6874487276326755650
- Leon, S., Shapiro, B., Sklaroff, D., Yaros, M. (1977). Free DNA in the serum of cancer patients and the effect of therapy. Cancer. Res., 37, 646–650.
- Liu, S. Q., Ma, X. B., Song, W. M., Li, Y. F., Li, N., Wang, L. N., Liu, J. Y., Tao, N. N., Li, S. J., Xu, T. T., Zhang, Q. Y., An, Q. Q., Liang, B., Li, H. C. (2021). Using a risk model for probability of cancer in pulmonary nodules. Thorac. Cancer, 12, 1881–1889.10.1111/1759-7714.13991820152633973725
- Lim, E., Baldwin, D., Beckles, M., Duffy, J., Entwisle, J., Faivre-Finn, C., Kerr, K., Macfie, A., McGuigan, J., Padley, S., et al. (2010). British Thoracic Society; Society for Cardiothoracic Surgery in Great Britain and Ireland. Guidelines on the radical management of patients with lung cancer. Thorax, 65, 1–27.10.1136/thx.2010.14593820940263
- Li, M.Y., Liu, L. Z., Dong, M. (2021). Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis. Mol. Cancer, 20, 1–22.10.1186/s12943-021-01312-y783920633504342
- Li, R. Y., Liang, Z. Y. (2020). Circulating tumor DNA in lung cancer: Real-time monitoring of disease evolution and treatment response. Chin. Med. J., 133, 2476–2485.10.1097/CM9.0000000000001097757518432960843
- Mandel, P., Metais, P. (1948). Les acides nucleiques du plasma sanguin chez l’homme. C.R. Acad. Sci. Paris, 142, 41–43.
- Marchevsky, A. M., Changsri, C., Gupta, I., Fuller, C., Houck, W., McKenna, R. J. Jr. (2004). Frozen section diagnoses of small pulmonary nodules: Accuracy and clinical implications. Ann. Thorac. Surg., 78, 1755–1759.10.1016/j.athoracsur.2004.05.00315511468
- Mok, T. S., Wu, Y.-L., Ahn, M.-J., Garassion, M. C., Kim, H. R., Ramalingam, S. S., Shepherd, S. A., He, Y., Akamatsu, H., Willemijn, S. M. E. (2017). Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer. New Engl. J. Med., 376, 629–640.10.1056/NEJMoa1612674676202727959700
- Mondelo-Macía, P., García-González, J., León-Mateos, L., Castillo-García, A., López-López, R., Muinelo-Romay, L., Díaz-Peńa. R. (2021). Current status and future perspectives of liquid biopsy in small cell lung cancer. Biomedicines, 9, 48.10.3390/biomedicines9010048782564533430290
- Montagne, F., Guisier, F., Venissac, N., Baste, J. M. (2021). The role of surgery in lung cancer treatment: Present indications and future perspectives — state of the art. Cancers, 13, 3711.10.3390/cancers13153711834519934359612
- National Lung Screening Trial Research Team, Aberle, D. R., Adams, A. M., Berg, C. D., Black, W. C., Clapp, J. D., Fagerstrom, R. M., Gareen, I. F., Gatsonis, C., Marcus, P. M., Sicks, J. D. (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. New Engl. J. Med., 365, 395–409.10.1056/NEJMoa1102873435653421714641
- NCCN (National Comprehensive Cancer Network) (2020). NCCN Guidelines Version 3. Non-Small Cell Lung Cancer. NCCN Evid. Books, 1–244.
- Oxnard, G. R., Paweletz, C. P., Kuang, Y., Mach, S. L., Fitzgerald, A. A., Messineo, M. M., Luke, J., Butaney, M., Kirschmeier, P. T., Jackman, D. M., Janne, P. A. (2014). Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA. Clin. Cancer Res. 20, 1698–1705.10.1158/1078-0432.CCR-13-2482395924924429876
- Ozkumur, E., Shah, A. M., Ciciliano, J. C., Emmink, B. L., Miyamoto, D. T., Brachtel, E., Chen, P. I., Morgan, B., Trautwein, J., Kimura, A., et al. (2013). Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci. Transl. Med. 5, 179ra47.10.1126/scitranslmed.3005616376027523552373
- Qian, F., Yang, W., Chen, Q., Zhang, X., Han, B. (2018). Screening for early stage lung cancer and its correlation with lung nodule detection. J. Thorac Dis., 10, S846–S859.10.21037/jtd.2017.12.123594569429780631
- Qian, K., Krimsky, W. S., Sarkar, S. A., Deng, Y. (2020). Efficiency of electromagnetic navigation bronchoscopy and virtual bronchoscopic navigation. Ann. Thorac. Surg., 109, 1731–1740.10.1016/j.athoracsur.2020.01.01932112724
- Peixoto da Silva, S., Caires, H. R., Bergantim, R., Guimarães, J. E., Vasconcelos, M. H. (2021). miRNAs mediated drug resistance in hemato-logical malignancies. Semin. Cancer. Biol., 83, 283–30210.1016/j.semcancer.2021.03.014
- Rami-Porta, R. (2016). IASLC Staging Handbook in Thoracic Oncology.2nd edn. International association for the study of lung cancer (IASLC). Rx Press North Fort Myers. 188 pp.
- Report on cancer statistics in Latvia 2001–2017. Centre for Disease Prevention and Control (CDPC), Latvia 2018.
- Rocco, G. (2018). Every breath you take: The value of the electronic nose (e-nose) technology in the early detection of lung cancer. J. Thorac. Cardiovasc. Surg., 155, 2622–2625.10.1016/j.jtcvs.2017.12.15529602425
- Rolfo, C., Mack, P. C., Scagliotti, G. V., Baas, P., Barlesi F., Bivona, T. G., Herbst, R. S., Mok, T. S., Peled, N., Pirker, R., et al. (2018). Liquid biopsy for advanced non-small cell lung cancer: A statement paper from the IASLC. J. Thorac. Oncol., 13, 1248–1268.10.1016/j.jtho.2018.05.03029885479
- Roweth, H. G., Battinelli, E. M. (2021). Lessons to learn from tumor-educated platelets. Blood, 137, 3174–3180.10.1182/blood.2019003976835188333940594
- Schwartzberg, L. S., Horinouchi, H., Chan, D., Chernilo, S., Tsai, M. L., Isla, D., Escriu, C., Bennett, J. P., Clark-Langone, K., Svedman, C., Tomasini, P. (2020). Liquid biopsy mutation panel for non-small cell lung cancer: Analytical validation and clinical concordance. NPJ Precis. Oncol., 4, 15.10.1038/s41698-020-0118-x731476932596507
- Serratì, S., De Summa, S., Pilato, B., Petriella, D., Lacalamita, R., Tommasi, S., Pinto, R. (2016). Next-generation sequencing: Advances and applications in cancer diagnosis. Onco. Targets. Ther., 9, 7355–7365.10.2147/OTT.S99807514490627980425
- Siravegna, G., Marsoni, S., Siena, S., Bardelli, A. (2017). Integrating liquid biopsies into the management of cancer. Nat. Rev. Clin. Oncol., 14, 531–548.10.1038/nrclinonc.2017.1428252003
- Smolle, E., Taucher, V., Lindenmann, J., Pichler, M., Smolle-Juettner, F. M. (2021). Liquid biopsy in non-small cell lung cancer-current status and future outlook-a narrative review. Transl. Lung. Cancer Res., 10, 2237–2251.10.21037/tlcr-21-3818270634164273
- Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin., 71, 209–249.10.3322/caac.2166033538338
- Tirzite, M., Bukovskis, M., Strazda, G., Jurka, N., Taivans, I. (2018). Detection of lung cancer with electronic nose and logistic regression analysis. J. Breath. Res., 13, 016006.10.1088/1752-7163/aae1b830221629
- Vansteenkiste, J., Crinò, L., Dooms, C., Douillard, J. Y., Faivre-Finn, C., Lim, E., Rocco, G., Senan, S., Van Schil, P., Veronesi, G., Stahel, R., Peters, S., Felip, E. (2014). 2nd ESMO Consensus Conference on Lung Cancer: Early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann. Oncol., 25, 1462–1474.10.1093/annonc/mdu08924562446
- Vasioukhin, V., Anker, P., Maurice, P., Lyautey, J., Lederrey, C., Stroun, M. (1994). Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Brit. J. Haematol., 86, 774–779.10.1111/j.1365-2141.1994.tb04828.x7918071
- van Geffen, W.H., Lamote, K., Costantini, A., Hendriks, L.E.L., Rahman, N.M., Blum, T.G., van Meerbeeck, J. (2019). The electronic nose: Emerging biomarkers in lung cancer diagnostics. Breathe. 15, 135-141.10.1183/20734735.0309-2019712187832280381
- Wang Memoli, J. S., Nietert, P. J., Silvestri, G. A. (2012). Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest. 142, 385–393.10.1378/chest.11-1764342533621980059
- Wang, P. P., Liu, S. H., Chen, C. T., Lv, L., Li, D., Liu, Q.-Y., Liu, G.-L., Wu, Y. (2020). Circulating tumor cells as a new predictive and prognostic factor in patients with small cell lung cancer. J. Cancer, 11, 2113–2122.10.7150/jca.35308705293532127938
- Wang, Y.H., Zhu, Z.R., Tong, D., Zhou, R., Xiao, K., Peng, L., et al. (2021). MicroRNAs and lung cancer: A review focused on targeted genes. Explor. Res. Hypothesis. Med., 6, 67–76.10.14218/ERHM.2020.00058
- Wang, Y., Springer, S., Mulvey, C. L., Silliman, N., Schaefer, J., Sausen, M., James, N., Rettig, E. M., Guo, T., Pickering, C. R., et al. (2015). Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas. Sci. Transl. Med., 7, 293ra104.10.1126/scitranslmed.aaa8507
- Wiener, R. S., Schwartz, L. M., Woloshin, S., Welch, H. G. (2011). Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: An analysis of discharge records. Ann. Intern. Med., 155, 137–44.10.7326/0003-4819-155-3-201108020-00003315096421810706
- Woodhouse, R., Li, M., Hughes, J., Delfosse, D., Skoletsky, J., Ma, P., Meng, W., Dewal, N., Milbury, C., Clark, T., et al. (2020). Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin. PLoS One, 15, e0237802.10.1371/journal.pone.0237802751858832976510
- Wu, K. L., Tsai, Y. M., Lien, C. T., Kuo, P. L., Hung, A. J. (2019). The roles of microRNA in lung cancer. Int. J. Mol. Sci., 20, 1611.10.3390/ijms20071611648047230935143
- Xia, S., Huang, C. C., Le, M., Dittmar, R., Du, M., Yuan, T., Guo, Y., Wang, Y., Wang, X., Tsai, S., Suster, S., Mackinnon, A. C., Wang, L. (2015). Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls. Lung Cancer, 90, 78–84.10.1016/j.lungcan.2015.07.00226233568
- Zeng, D., Wang, C., Mu, C., Su, M., Mao, J., Huang, J., Xu, J., Shao, L., Li, B., Li, H., Li, B., Zhao, J., Jiang, J. (2021). Cell-free DNA from broncho-alveolar lavage fluid (BALF): A new liquid biopsy medium for identifying lung cancer. Ann. Transl. Med., 9, 1080.10.21037/atm-21-2579
- Zhang, X., Yuan, X., Shi, H., Wu, L., Qian, H., Xu, W. (2015). Exosomes in cancer: Small particle, big player. J. Hematol. Oncol., 8, 83.10.1186/s13045-015-0181-x449688226156517
- Zhang, J., Chen, K., Fan, Z. H. (2016). Circulating tumor cell isolation and analysis. Adv. Clin. Chem., 75, 1–31.10.1016/bs.acc.2016.03.003512369927346614
- Zhang, Y. C., Zhou, Q., Wu, Y. L. (2017). The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer. J. Hematol. Oncol., 10, 167.10.1186/s13045-017-0536-6565412429061113
- Zhang, W., Chen, S., Dong, X., et al. (2015). Meta-analysis of the diagnostic yield and safety of electromagnetic navigation bronchoscopy for lung nodules. J. Thorac. Dis., 7, 799–809.
- Zhao, Q., Yuan, Z., Wang, H., Zhang, H., Duan, G., Zhang, X. (2021). Role of circulating tumor cells in diagnosis of lung cancer: A systematic review and meta-analysis. J. Int. Med. Res., 49, 300060521994926.10.1177/0300060521994926794454433682521